Abstract
Background
Increasing evidence supports lung cancer screening with low-dose CT (LDCT) imaging. However, the benefits of LDCT screening for lung cancer may not be immediate, making it unlikely to benefit patients with limited life expectancy.
Research Question
What is the time to benefit (TTB) from LDCT screening for individuals at high risk for lung cancer?
Increasing evidence supports lung cancer screening with low-dose CT (LDCT) imaging. However, the benefits of LDCT screening for lung cancer may not be immediate, making it unlikely to benefit patients with limited life expectancy.
Research Question
What is the time to benefit (TTB) from LDCT screening for individuals at high risk for lung cancer?
| Original language | English |
|---|---|
| Pages (from-to) | 1049-1056 |
| Number of pages | 8 |
| Journal | Chest |
| Volume | 168 |
| Issue number | 4 |
| Early online date | 18 Jun 2025 |
| DOIs | |
| Publication status | Published - 1 Oct 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- clinical benefit
- low-dose CT
- lung cancer
- screening
Fingerprint
Dive into the research topics of 'Timing of Screening Benefit for Lung Cancer With Low-Dose CT Imaging'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver